Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Perdiguero · SciRah

Researcher profile · Semantic Scholar

B. Perdiguero

Share profile

B. Perdiguero — researcher profile on SciRah

h-index: 29
Works: 77
Citations: 2,799

Most-cited papers

Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
J. Delaloye, T. Roger, Quynh-Giao Steiner-Tardivel, D. Le Roy +9 more
2009PLoS Pathogens333 citations Open access
Semantic Scholar
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
C. E. Gómez, B. Perdiguero, M. Esteban
2021Vaccines243 citations Open access
Semantic Scholar
The Evolution of Poxvirus Vaccines
L. Sánchez-Sampedro, B. Perdiguero, E. Mejías-Pérez, J. García-Arriaza +2 more
2015Viruses196 citations Open access
Semantic Scholar
The Interferon System and Vaccinia Virus Evasion Mechanisms
B. Perdiguero, M. Esteban
2009Journal of Interferon and Cytokine Research187 citations Open access
Semantic Scholar
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
Barbara Flynn, Kathrin Kastenmüller, U. Wille-Reece, G. Tomaras +13 more
2011Proceedings of the National Academy of Sciences of the United States of America143 citations Open access
Semantic Scholar
Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein.
M. M. Geada, I. Galindo, M. Lorenzo, B. Perdiguero +1 more
2001Journal of General Virology110 citations Open access
Semantic Scholar
MVA and NYVAC as vaccines against emergent infectious diseases and cancer.
C. E. Gómez, J. L. Nájera, M. Krupa, B. Perdiguero +1 more
2011Current Gene Therapy108 citations
Semantic Scholar
Cryo X-ray nano-tomography of vaccinia virus infected cells
F. J. Chichón, María Josefa Rodríguez, E. Pereiro, M. Chiappi +7 more
2011Journal of Structural Biology80 citations Open access
Semantic Scholar
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
F. García, Juan Carlos López Bernaldo de Quirós, C. E. Gómez, B. Perdiguero +22 more
2011Vaccine79 citations Open access
Semantic Scholar
Poxvirus vectors as HIV/AIDS vaccines in humans
Carmen Elena Gómez, B. Perdiguero, J. García-Arriaza, M. Esteban
2012Human Vaccines & Immunotherapeutics78 citations Open access
Semantic Scholar
The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens
C. E. Gómez, J. L. Nájera, B. Perdiguero, J. García-Arriaza +11 more
2011Journal of Virology76 citations Open access
Semantic Scholar
Clinical applications of attenuated MVA poxvirus strain
C. E. Gómez, B. Perdiguero, J. García-Arriaza, M. Esteban
2013Expert Review of Vaccines73 citations
Semantic Scholar
Improved NYVAC-Based Vaccine Vectors
K. Kibler, C. E. Gómez, B. Perdiguero, Shukmei Wong +13 more
2011PLoS ONE69 citations Open access
Semantic Scholar
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.
B. Mothe, N. Climent, M. Plana, M. Rosás +26 more
2015Journal of Antimicrobial Chemotherapy58 citations
Semantic Scholar
Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein
J. Falivene, M. P. Del Médico Zajac, M. Pascutti, A. M. Rodríguez +6 more
2012PLoS ONE58 citations Open access
Semantic Scholar
Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors
E. Quakkelaar, A. Redeker, E. Haddad, A. Harari +19 more
2011PLoS ONE53 citations Open access
Semantic Scholar
Interaction between Vaccinia Virus Extracellular Virus Envelope A33 and B5 Glycoproteins
B. Perdiguero, R. Blasco
2006Journal of Virology49 citations Open access
Semantic Scholar
Removal of Vaccinia Virus Genes That Block Interferon Type I and II Pathways Improves Adaptive and Memory Responses of the HIV/AIDS Vaccine Candidate NYVAC-C in Mice
C. E. Gómez, B. Perdiguero, J. L. Nájera, C. O. Sorzano +3 more
2012Journal of Virology46 citations Open access
Semantic Scholar
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
Sandrine L. Hulot, B. Korber, E. Giorgi, N. Vandergrift +26 more
2015Journal of Virology42 citations Open access
Semantic Scholar
High, Broad, Polyfunctional, and Durable T Cell Immune Responses Induced in Mice by a Novel Hepatitis C Virus (HCV) Vaccine Candidate (MVA-HCV) Based on Modified Vaccinia Virus Ankara Expressing the Nearly Full-Length HCV Genome
C. E. Gómez, B. Perdiguero, M. Cepeda, Lidia Mingorance +4 more
2013Journal of Virology42 citations Open access
Semantic Scholar
Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic Frontiers
Enrique Álvarez, M. Falqui, Laura Sin, J. McGrail +7 more
2024Vaccines39 citations Open access
Semantic Scholar
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
J. García-Arriaza, B. Perdiguero, J. Heeney, M. Seaman +28 more
2015Journal of Virology39 citations Open access
Semantic Scholar
Deletion of the Viral Anti-Apoptotic Gene F1L in the HIV/AIDS Vaccine Candidate MVA-C Enhances Immune Responses against HIV-1 Antigens
B. Perdiguero, C. E. Gómez, J. L. Nájera, C. O. Sorzano +7 more
2012PLoS ONE35 citations Open access
Semantic Scholar
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases
B. Perdiguero, Patricia Pérez, L. Marcos-Villar, Guillermo Albericio +6 more
2023Journal of Molecular Biology34 citations Open access
Semantic Scholar
Virological and Immunological Characterization of Novel NYVAC-Based HIV/AIDS Vaccine Candidates Expressing Clade C Trimeric Soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as Virus-Like Particles
B. Perdiguero, C. E. Gómez, V. Cepeda, L. Sánchez-Sampedro +15 more
2014Journal of Virology32 citations Open access
Semantic Scholar
Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C
B. Perdiguero, C. E. Gómez, Mauro Di Pilato, C. O. Sorzano +5 more
2013PLoS ONE32 citations Open access
Semantic Scholar
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost
B. Asbach, K. Kibler, J. Köstler, B. Perdiguero +25 more
2018Journal of Virology30 citations Open access
Semantic Scholar
Vaccinia Virus A34 Glycoprotein Determines the Protein Composition of the Extracellular Virus Envelope
B. Perdiguero, M. Lorenzo, R. Blasco
2007Journal of Virology30 citations Open access
Semantic Scholar
NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses
Mauro Di Pilato, E. Mejías-Pérez, M. Zonca, B. Perdiguero +9 more
2015Proceedings of the National Academy of Sciences of the United States of America29 citations Open access
Semantic Scholar
Involvement of the Cellular Phosphatase DUSP1 in Vaccinia Virus Infection
A. Cáceres, B. Perdiguero, C. E. Gómez, M. Cepeda +3 more
2013PLoS Pathogens28 citations Open access
Semantic Scholar
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens
B. Asbach, A. Kliche, J. Köstler, B. Perdiguero +28 more
2016Journal of Virology27 citations Open access
Semantic Scholar
A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART
C. E. Gómez, B. Perdiguero, J. García-Arriaza, V. Cepeda +9 more
2015PLoS ONE26 citations Open access
Semantic Scholar
New vaccinia virus promoter as a potential candidate for future vaccines.
Mauro Di Pilato, E. Mejías-Pérez, C. E. Gómez, B. Perdiguero +2 more
2013Journal of General Virology26 citations Open access
Semantic Scholar
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Prima
J. García-Arriaza, B. Perdiguero, J. Heeney, M. Seaman +22 more
2017Journal of Virology25 citations Open access
Semantic Scholar
Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same Antigen
C. E. Gómez, B. Perdiguero, Lorena Usero, L. Marcos-Villar +7 more
2021Vaccines19 citations Open access
Semantic Scholar
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
A. Guardo, C. E. Gómez, V. Díaz-Brito, J. Pich +14 more
2017PLoS ONE18 citations Open access
Semantic Scholar
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector
Maryann Giel-Moloney, Mariano Esteban, B. Oakes, M. Vaine +30 more
2019Scientific Reports16 citations Open access
Semantic Scholar
Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant
C. E. Gómez, B. Perdiguero, M. Falqui, María Q. Marín +5 more
2020Journal of Virology15 citations Open access
Semantic Scholar
A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular Immunity
L. Pattacini, Gregory Mize, Jessica B. Graham, Tayler R. Fluharty +10 more
2012PLoS ONE14 citations Open access
Semantic Scholar
Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses
B. Perdiguero, C. E. Gómez, J. García-Arriaza, Cristina Sánchez-Corzo +12 more
2019Frontiers in Immunology13 citations Open access
Semantic Scholar
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC
K. Kibler, B. Asbach, B. Perdiguero, J. García-Arriaza +24 more
2018Journal of Virology13 citations Open access
Semantic Scholar
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
L. Marcos-Villar, B. Perdiguero, M. López-Bravo, Carmen Zamora +23 more
2024Emerging Microbes and Infections12 citations Open access
Semantic Scholar
An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses
M. Falqui, B. Perdiguero, R. Coloma, Manuel Albert +6 more
2023Frontiers in Cellular and Infection Microbiology12 citations Open access
Semantic Scholar
A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses
B. Perdiguero, Cristina Sánchez-Corzo, C. O. Sorzano, Lidia Saiz +3 more
2019Viruses12 citations Open access
Semantic Scholar
Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C
C. E. Gómez, B. Perdiguero, V. Jiménez, A. Filali-Mouhim +15 more
2012Retrovirology12 citations Open access
Semantic Scholar
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
L. Marcos-Villar, B. Perdiguero, Shubaash Anthiya, Mireya L Borrajo +19 more
2024npj Vaccines11 citations Open access
Semantic Scholar
Interleukin-1- and Type I Interferon-Dependent Enhanced Immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef Vaccine Vector with Dual Deletions of Type I and Type II Interferon-Binding Proteins
J. Delaloye, A. Filali-Mouhim, M. Cameron, E. Haddad +9 more
2015Journal of Virology11 citations Open access
Semantic Scholar
Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B
B. Perdiguero, Suresh C. Raman, Cristina Sánchez-Corzo, C. O. Sorzano +3 more
2018Viruses9 citations Open access
Semantic Scholar
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses
Lorena Usero, L. Leal, C. E. Gómez, L. Miralles +8 more
2023Vaccines8 citations Open access
Semantic Scholar
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates
K. Saunders, S. Santra, Robert Parks, N. Yates +22 more
2018Journal of Virology8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Esteban×42
Invite
M. Esteban — researcher profile on SciRah
C. E. Gómez×36
Invite
C. E. Gómez — researcher profile on SciRah
G. Pantaleo×20
Invite
G. Pantaleo — researcher profile on SciRah
J. García-Arriaza×17
Invite
J. García-Arriaza — researcher profile on SciRah

×17

Invite

C. O. Sorzano — researcher profile on SciRah

Invite

R. Wagner — researcher profile on SciRah

Invite

K. Kibler — researcher profile on SciRah

J. Tartaglia×9

Invite

J. Tartaglia — researcher profile on SciRah

Invite

B. Jacobs — researcher profile on SciRah

Invite

G. Tomaras — researcher profile on SciRah

Invite

M. Plana — researcher profile on SciRah

Invite

S. Phogat — researcher profile on SciRah